Game-changing heart valve procedure approved by FDA
We’re excited to announce the the U.S. Food and Drug Administration (FDA) officially approved what’s being called a “game-changing” heart valve procedure, which will provide many with a chance at a longer life.
Why is transcatheter aortic valve replacement considered a game-changer? It let’s patients who are considered too high-risk for surgery to have open-heart surgery without the “open”.
The Washington University and Barnes-Jewish Heart & Vascular Center was one of only 23 centers in the nation to participate in the nationwide PARTNER (Placement of AoRTic traNscathetER valves) trial which lead to the FDA’s approval. We are proud to have been part of such an important trial and to have treated many in our community with this procedure, and are looking forward to treating many more.
For more on this breaking news, read our official press release here.
We also have an event coming up called “Open Heart Surgery Without The Open” on December 7th which will feature Washington University Cardiothoracic Surgeon Hersh Maniar, MD, and Cardiologist Alan Zajarias, MD, discussing the procedure in detail and taking questions from the attendees. To register for this event, go here.
It’s a pretty incredible procedure – to get a closer look at it, watch the video below.